The EveryPrem Project
about the EveryPrem Project
The EveryPrem Project is evaluating a new, international tool INTER-NDA to measure neurodevelopment in 2 year-old children, who were born at less than 37 weeks of pregnancy, against the current developmental testing offered by the Neonatal Team at the John Radcliffe Hospital, Oxford to children. The purpose of the study is to assess the effectiveness, medium-term patient benefits and health care costs of this new neurodevelopmental test for all children, at 2 years of age, who were born preterm (at less than 37 weeks of pregnancy) at the John Radcliffe Hospital, Oxford, between April 2017 and April 2019.
Read how the EveryPrem Project is evaluating the INTER-NDA for standardized neurodevelopmental screening at 2 years of age for all children born preterm.
RISKS, BENEFITS & FAQs
Read about the possible benefits, disadvantages and risks of taking part, our commitment to confidentiality, expenses, what happens to the results and more.
For General Practitioners, please see more information about the study here. For access to the full research proposal, please click here.
(ELIGIBLE PARENTS ONLY)